Funding and regulation blocking the potential of personalised medicine

Lack of investment and regulatory hurdles are holding back the development of personalised healthcare technology in Europe, despite its potential to cut clinical errors and costs.According to a survey by Swedish medical university Karolinska Institutet in association with Science|Business, the majority of stakeholders believe personalised healthcare, such as the use of genetic data and patient…